Glutamine supplementation in catabolic patients

Area of Science:

• Clinical Nutrition
• Metabolic Support
• Amino Acid Metabolism

Background:

• Glutamine is a crucial metabolic fuel for enterocytes, lymphocytes, and macrophages.
• It plays a vital role in maintaining intestinal function, immune response, and amino acid homeostasis during severe stress.
• Originally considered nonessential, glutamine is now recognized as conditionally essential during critical illness.

Purpose of the Study:

• To evaluate the safety and efficacy of parenteral and enteral glutamine supplementation.
• To assess glutamine's impact on amino acid metabolism, immune function, and patient outcomes in catabolic states.

Main Methods:

• Systematic review of English-language clinical trials and review articles (1970-1997).
• Searches included MEDLINE and bibliographies using keywords: glutamine, critical illness, stress, catabolism, injury, enteral nutrition, parenteral nutrition.
• Inclusion criteria focused on studies evaluating glutamine safety, metabolism, immune function, and patient outcomes.

Main Results:

• Glutamine supplementation in metabolically stressed patients improves nitrogen balance and cellular proliferation.
• It has been shown to decrease infection incidence and shorten hospital stays in some catabolic patients.
• Clinical trials indicate glutamine is well-tolerated without adverse effects, even during stress.

Conclusions:

• Glutamine supplementation is safe and well-tolerated in critically ill patients.
• It shows promise in improving outcomes for select catabolic patient populations.
• Further research is needed to identify specific patient groups benefiting most from glutamine and elucidate its mechanisms of action.